| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026901067 |
| P356 | DOI | 10.1007/S00213-008-1431-1 |
| P932 | PMC publication ID | 2818041 |
| P698 | PubMed publication ID | 19125238 |
| P5875 | ResearchGate publication ID | 23760269 |
| P50 | author | Perry F Renshaw | Q87441912 |
| P2093 | author name string | David M Penetar | |
| Stephanie C Licata | |||
| Andrew P Prescot | |||
| Scott E Lukas | |||
| J Eric Jensen | |||
| P2860 | cites work | Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human [...] | Q24316082 |
| Benzodiazepine receptors mediate regional blood flow changes in the living human brain | Q24564373 | ||
| The neural representation of postural control in humans | Q24674114 | ||
| Type I and type II GABAA-benzodiazepine receptors produced in transfected cells | Q28342945 | ||
| Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of National Ambulatory Medical Survey data, 1997-2002. | Q31061847 | ||
| Quantitative proton short-echo-time LASER spectroscopy of normal human white matter and hippocampus at 4 Tesla incorporating macromolecule subtraction | Q31139453 | ||
| Simultaneous in vivo spectral editing and water suppression | Q31982014 | ||
| Central nervous system side effects associated with zolpidem treatment | Q33842608 | ||
| Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. | Q33902217 | ||
| Amnestic sleep-related eating disorder associated with zolpidem | Q34273538 | ||
| Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications | Q34367180 | ||
| State transitions between wake and sleep, and within the ultradian cycle, with focus on the link to neuronal activity | Q34369907 | ||
| Zolpidem-induced psychosis | Q34397167 | ||
| One rare side effect of zolpidem--sleepwalking: a case report | Q34426200 | ||
| Zolpidem-Induced Distortion in Visual Perception | Q35112384 | ||
| Organization of the pontine nuclei | Q35317855 | ||
| Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey | Q36024609 | ||
| Zolpidem and amnestic sleep related eating disorder. | Q36099704 | ||
| GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits | Q36790682 | ||
| Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania | Q36960864 | ||
| A therapeutic dose of zolpidem has limited abuse-like effects in drug-naïve females: a pilot study | Q36978448 | ||
| Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys | Q37132185 | ||
| Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential | Q37977354 | ||
| The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon | Q38330309 | ||
| The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure | Q39691888 | ||
| Differential effects in humans after repeated administrations of zolpidem and triazolam | Q40586622 | ||
| Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia | Q40798302 | ||
| Behavioral pharmacology of zolpidem relative to benzodiazepines: a review | Q40840240 | ||
| Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects | Q40862223 | ||
| Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder | Q42471129 | ||
| GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. | Q42497057 | ||
| A Case Report of Zolpidem-Induced Somnambulism | Q42720498 | ||
| Effects of zolpidem on local cerebral glucose metabolism during non-REM sleep in normal volunteers: a positron emission tomography study | Q43467627 | ||
| Gamma amino butyric acid (GABA) immunoreactivity in the vestibular nuclei of normal and unilateral vestibular neurectomized cats | Q43674634 | ||
| Delirium associated with zolpidem | Q43856258 | ||
| 1H MRS brain measures and acute lorazepam administration in healthy human subjects | Q43942952 | ||
| Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes | Q44136555 | ||
| Zolpidem dependence case series: possible neurobiological mechanisms and clinical management | Q44393749 | ||
| Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. | Q44578871 | ||
| A novel clinical pattern of visual hallucination after zolpidem use. | Q44694780 | ||
| Temporal changes in postural sway caused by ultrashort-acting hypnotics: triazolam and zolpidem | Q46430724 | ||
| Vestibular signals in primate thalamus: properties and origins. | Q48027769 | ||
| Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus | Q48176150 | ||
| Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy | Q48243848 | ||
| Compulsive activity and anterograde amnesia after zolpidem use. | Q48474516 | ||
| Midazolam changes cerebral blood flow in discrete brain regions: an H2(15)O positron emission tomography study | Q48596093 | ||
| ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra | Q48616303 | ||
| Functional neuroanatomy of human sleep states after zolpidem and placebo: a H215O-PET study. | Q48720455 | ||
| Zolpidem tartrate and somnambulism | Q48743448 | ||
| Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans | Q48750846 | ||
| Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans | Q48773812 | ||
| Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases | Q48788680 | ||
| Depression of thalamic metabolism by lorazepam is associated with sleepiness | Q48822520 | ||
| Zolpidem in insomnia: a 3-year post-marketing surveillance study in Switzerland | Q48827550 | ||
| Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia | Q48875962 | ||
| Reproducibility of regional brain metabolic responses to lorazepam | Q48909274 | ||
| Implementation issues of multivoxel STEAM-localized 1H spectroscopy | Q49028798 | ||
| Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. | Q51080503 | ||
| Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. | Q51434685 | ||
| Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure. | Q52181276 | ||
| Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers. | Q52202232 | ||
| The α 4 Subunit of the GABA A Receptors from Rat Brain and Retina | Q60462295 | ||
| In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype | Q69830700 | ||
| Estimation of metabolite concentrations from localized in vivo proton NMR spectra | Q72319396 | ||
| Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI) | Q72772867 | ||
| P433 | issue | 4 | |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 819-829 | |
| P577 | publication date | 2009-01-06 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. | |
| P478 | volume | 203 |
| Q30775959 | Contributions of magnetic resonance spectroscopy to understanding development: potential applications in the study of adolescent alcohol use and abuse |
| Q48257449 | Effects of prolonged-release melatonin and zolpidem on postural stability in older adults |
| Q35893100 | Efficacy of zolpidem for dystonia: a study among different subtypes |
| Q36961751 | Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition |
| Q34135715 | GABA-based evaluation of neurologic conditions: MR spectroscopy. |
| Q35121218 | GABAergic contributions to alcohol responsivity during adolescence: insights from preclinical and clinical studies |
| Q36060201 | In vivo magnetic resonance spectroscopy of GABA: a methodological review |
| Q34802627 | Modest abuse-related subjective effects of zolpidem in drug-naive volunteers |
| Q33536778 | Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction |
| Q35892779 | Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder? |
| Q47374124 | Reliable gamma aminobutyric acid measurement using optimized PRESS at 3 T. |
| Q92404163 | Zolpidem for the Treatment of Dystonia |
| Q48812645 | γ-aminobutyric acid as a metabolite: Interpreting magnetic resonance spectroscopy experiments |
Search more.